Get In Touch
Have any questions or comments about the content you see on this page?
July 24, 2023
At Alnylam, we're intensely focused on ensuring that ours is a workplace where all employees are supported, feel that they belong, and can thrive. Our culture and core values reflect this focus, and we know that attracting and retaining early to mid-career employees is critical to our mission of bringing truly innovative new treatments to patients.
That's why were so proud to be named a Best Workplace for Millennials for 2023 by Fortune magazine and Great Place to Work. We're ranked #19 on the list of top 100 "Large" companies joining such well respected, global companies as Cisco, NVIDIA, Hilton, American Express, Accenture, Salesforce, Stryker and Adobe and we're the highest ranked Biotechnology & Pharmaceuticals company on the list.
This prestigious and highly-regarded annual list recognizes companies that provide millennials a work experience "based on trust, respect, credibility, fairness, pride, and camaraderie."
Our millennial colleagues have told us they value Alnylam for our authentic leadership, meaningful work, and healthy work environment. We are immensely proud of this recognition from Fortune, which we feel is a true testament of our commitment to our people – one of the core values that we hold dear.” - Kelley Boucher, Chief Human Resources Officer
From Great Place to Work: "In the last year, Great Place To Work surveyed companies employing 7.5 million people in the U.S. and received 1.3 million survey responses. Of those, nearly 500,000 responses were received from millennials at companies who were eligible for the 2023 Fortune Best Workplaces for Millennials list and this list is based on their feedback." See the full list here.
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.Proceed to Site